معرفی
Allon Edward Moses serves as a Visiting Professor in the Department of Microbiology and Immunology at the School of Medicine, European University Cyprus, while maintaining active clinical leadership as Senior Physician at Hadassah-Hebrew University Medical Center in Jerusalem since 1991, including tenure as Head of Department (2005-2020).
His academic credentials include:
- MD, Ben Gurion University of the Negev, Israel (1981)
- Residency in Medicine, Hadassah Hebrew University Medical Center (1988)
- Infectious Diseases Fellowship, Harvard Medical School (1991)
Dr. Moses' research centers on infectious disease pathogenesis with emphasis on microbiome dynamics, antibiotic resistance mechanisms, and streptococcal infections. His work bridges clinical practice and translational research, addressing critical challenges in infection control and novel therapeutic interventions for resistant pathogens through hospital-based epidemiological studies.
His publication trajectory (2013-2022) reveals evolving expertise from bacterial genetics (sil characterization, 2013) to contemporary pandemic responses (COVID-19 vaccine efficacy, 2022), with consistent focus on microbiome applications (vaginal transplantation, 2019) and alternative antimicrobial strategies (bacteriophage therapy, 2019). These studies demonstrate methodological diversity across cohort analyses, cross-sectional behavioral research, and therapeutic case reports.
No major scientific awards are documented in the provided information.
Research funding includes the human microbiome of the external ear canal project (2021-2022), and the politically impacted antibiotic stewardship initiative in Palestinian hospitals (2023-2025) funded by USAID's Middle East Regional Cooperation Program (MERC), which was approved but withheld following US policy changes regarding Palestinian Authority funding. He also contributed to the government-sponsored project "Reduction of Hospital Acquired Infections in Israeli and Palestinian Hospitals".
Dr. Moses maintains extensive clinical-research collaborations across Israeli medical centers, particularly Hadassah-Hebrew University teams, with documented partnerships spanning infectious disease epidemiology, microbiome therapeutics, and cross-border public health initiatives despite geopolitical constraints.
